Borage Seed Oil (Borago officinalis).

EPA slows the delta-5 desaturase step, so DGLA formed from borage GLA is held at the series-1 eicosanoid arm rather than carried on to arachidonic acid. This is why the two oils are so often bottled together.

Borage seed oil carries both linoleic acid and its delta-6 desaturase product GLA. The preformed GLA steps past the rate-limiting conversion that linoleic acid alone depends on.

A seed oil this unsaturated peroxidises quickly without a chain-breaking antioxidant. Tocopherol is the standard companion that keeps the fatty acid profile intact through shelf life and after absorption.

Ascorbate returns spent tocopherol to its active form at the lipid boundary. That loop lets modest vitamin E cover a large polyunsaturated load.

Zinc status governs delta-6 desaturase activity, the enzyme that makes GLA from linoleic acid. Adequate zinc keeps the wider omega-6 chain moving normally alongside the preformed GLA.

Cholecalciferol needs dietary fat to enter mixed micelles. Taken in or with the seed oil, its uptake is markedly better than from a dry tablet on an empty stomach.

CoQ10 is a large lipophilic quinone with poor uptake from powder. An oil carrier such as borage seed oil is the standard way to get it into micelles.

GLA feeds prostaglandin E1, which damps normal platelet aggregation, and ginkgolides block platelet activating factor. Both push the same physiology in the same direction.

Garlic sulfur compounds independently lower normal platelet aggregation. Stacked with a GLA oil the effect adds rather than cancels.

Nattokinase acts on fibrin handling while GLA-derived prostaglandin E1 acts on platelets. The two arms of normal clotting are affected together.

Delta-6 desaturase activity depends on adequate pyridoxine, zinc and magnesium status. That enzyme is the step borage oil bypasses, since the oil already supplies gamma-linolenic acid. B6 still matters for the elongation and desaturation of the rest of the dietary fatty acid pool. Textbook biochemistry rather than a combination trial.

Magnesium is required for the desaturase and elongase steps that convert dietary fatty acids along the n-6 series. Low magnesium status slows that machinery regardless of how much precursor is supplied. Established biochemistry, offered as the reason the pairing appears in formulas.

Biotin is the cofactor for acetyl-CoA carboxylase and so sits at the head of endogenous fatty acid synthesis, and biotin status has been linked to desaturase activity in animal work. It supports the machinery around a supplied fatty acid rather than the fatty acid itself. Established cofactor biology applied to a pairing no human trial has measured.

Both oils supply gamma-linolenic acid, borage at a notably higher percentage of total fatty acids than evening primrose. Taking both means adding two doses of the same active fatty acid rather than two different mechanisms. Anyone combining them should count total GLA, not total oil.

Gamma-linolenic acid is the constituent borage seed oil is taken for, so a separate GLA product is the same active in a different wrapper. Doses add directly. Stated so a stack does not double the same fatty acid without anyone noticing.

Alpha-linolenic acid from flax and the n-6 series both move through the same delta-6 desaturase and elongase enzymes, so they compete for that capacity. Large amounts of one shift the balance of what the pathway produces from the other. This is established competition, not a claim about which balance is preferable.

GLA is elongated to dihomo-gamma-linolenic acid, which can either form series-1 prostanoids or be desaturated onward to arachidonic acid. EPA inhibits that onward desaturation step and competes with arachidonic acid at cyclooxygenase. Combining the two changes which products dominate, which is why GLA and marine oils are often taken together.

Krill oil supplies EPA and DHA in phospholipid form, and those long-chain n-3 fatty acids constrain the conversion of DGLA onward to arachidonic acid. The pairing is about steering the pathway rather than adding more of the same. Mechanistic grounding at the level of established fatty acid metabolism.

Borage oil is high in polyunsaturated fatty acids, which oxidise readily once the seal is broken. Tocotrienols and tocopherols terminate the peroxidation chain in the oil phase, which protects the product and the ingested lipid. This is oil stability chemistry, distinct from any physiological effect.

Rosemary extract is a standard oil-phase antioxidant used in polyunsaturated oil products because its phenolic diterpenes slow peroxide formation. It protects the GLA content over shelf life. A quality partner rather than a physiological one.

Astaxanthin is a membrane-spanning carotenoid that resists becoming a pro-oxidant, which is why it is paired with polyunsaturated oils in softgels. The pairing addresses lipid oxidation in the product and in membranes. Early confidence for any added physiological effect.

Borage oil is a triglyceride, and its fatty acids are released only after pancreatic lipase hydrolyses the glycerol backbone. Where lipase output is low, fat absorption falls and so does GLA delivery. Established digestion biochemistry rather than an enhancement claim for people digesting fat normally.

Bile salts emulsify dietary triglyceride into micelles so lipase can act and the products can cross the enterocyte membrane. Anyone with reduced bile flow absorbs less of an oil dose. The relationship is established physiology; the supplemental pairing has not been measured with borage oil specifically.

Phospholipid emulsifiers help disperse an oil into an emulsion or a chewable format and support micelle formation during digestion. The effect is on dispersion and mouthfeel more than on total absorption in a person with normal bile flow. Formulation-level grounding.

Medium-chain triglycerides are absorbed by a partly different route from long-chain fats and are often used to dilute a concentrated oil to a workable dose. They dilute the GLA percentage of the finished blend rather than adding to it. Read a blend's GLA figure, not its total oil weight.

Curcumin acts on cyclooxygenase and NF-kB signalling in laboratory systems, and the DGLA route from GLA shifts which prostanoid series predominates. The two touch the same signalling network from different angles. Combination has not been measured in people, so this is a mechanistic pairing.

Boswellic acids act on 5-lipoxygenase in laboratory work, while DGLA derived from GLA yields 15-HETrE, which itself constrains that same enzyme. Both point at the lipoxygenase branch. Mechanistic overlap, without a trial of the pair.

Ginger constituents reduce thromboxane-driven platelet aggregation, and GLA-derived series-1 prostanoids push in the same antiaggregatory direction. Two agents on the same side of that balance are worth flagging together. Relevant to anyone on anticoagulant or antiplatelet therapy.

Salicin from willow bark is converted to salicylate, which reduces platelet aggregation through cyclooxygenase. Combined with a GLA source that shifts prostanoid balance the same way, the effects add. Flagged as an additive-effect consideration rather than a benefit.

Borage plant material naturally contains pyrrolizidine alkaloids, which undergo hepatic cytochrome P450 metabolism, and this is why seed oil is specified as alkaloid-tested. Silymarin is studied for hepatic handling generally. The pairing is early and speculative, and the real control is buying oil tested for alkaloid content.

A broad enzyme blend includes lipase, which is the component relevant to an oil, so the rest of the blend does little for borage oil specifically. Any benefit is limited to people whose fat digestion is genuinely reduced. Stated so a formula does not claim an absorption gain that normal digestion already delivers.